How many investments has Artis Ventures made?

Artis Ventures has 83 tracked investments, 9 of which have exited, including 4 dated in the last 24 months.

What stage does Artis Ventures invest at?

Artis Ventures invests at the Seed, Series A, Series B stages.

What is Artis Ventures's typical check size?

Artis Ventures typically writes checks of $50K – $25M.

Where is Artis Ventures located?

Artis Ventures is headquartered in San Francisco, US.

Does Artis Ventures lead rounds?

Yes, Artis Ventures leads investment rounds.

Who does Artis Ventures co-invest with?

Artis Ventures most often shares deals with Wing, Abstract Ventures, New Enterprise Associates (NEA), among 336 tracked co-investors.

Artis Ventures

Venture capitalActively deployingoperating company · company profile

San Francisco · Seed–Series B · 45 people tracked

Also known as ARTIS · ARTIS VENTURES MANAGEMENT, L.P.

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Artis Ventures

Paths you didn't know you had: your email and LinkedIn already hold routes to the Artis Ventures team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

ARTIS Ventures invests at the intersection of technology and biology, a space it refers to as 'TechBio,' backing companies that harness advances such as AI, machine learning, single-cell and multi-omics data, and computational tools to accelerate drug discovery and improve human health. The firm concentrates heavily on healthcare, life sciences, therapeutics, and biotech, while also investing in adjacent frontier technologies including fintech and consumer. It supports founders throughout their company lifecycle, providing board-level involvement and access to its network of 'Healthcare Pioneers'—senior executives from biotech, pharma, and healthcare—plus a fellowship of scientists and clinicians who help translate academic science into the clinic.

Invests inAI & Machine Learning Biotech Consumer Deep Tech Digital Health Fintech Healthtech Longevity Medical Devices San Francisco United States

Source: firm website, verified Sep 29, 2026.

Leave your own feedback

Stage

Seed–Series B

Check

$50K – $25M

San Francisco, CA, US

Leads rounds

Leads

Instruments

Equity

Founded

2022

Last 12 months

1 investment

Private fund assets

$824.5M

VC funds

Tracked investments

Unicorns

IPOs

Acquisitions

Team · 45 people

from the firm's website & curated & public directories

Jeff Sheedy· Partnerin

Director of International Marketing, joining in 2012. He previously worked at JP Morgan in Chicago serving high net worth clients and family offices, and spent 15 years overseas as CEO of a holding company with operations in manufacturing, oil services, agriculture, and consumer products.

Paul Johnson· Featured Pioneer (General Partner, Flex Capital) — not staff

Operating Partner who founded ARTIS portfolio company Lemonaid Health, a national direct-to-consumer telehealth provider, leading it to a $400M exit to 23andMe in 2021. An ARTIS advisor since 2021, he became Operating Partner in 2024 and serves as a board director of Eko Health.

Ruchita Sinha· Senior Partner· San Francisco Bay Areain

Ruchita Sinha combines deep cellular and molecular biology training with an MBA in finance and Sanofi‑Genzyme BioVentures leadership experience to offer technical, pharma-focused guidance on company and clinical program design.

ruchita@av8.vc

Austin Walne· Senior Partner· San Francisco, Californiain 𝕏

Partner focused on breakthrough technologies at the convergence of technology and biology. He previously advised institutional investors in the private secondary market and worked in software development and product management, and serves on boards including Second Front Systems and Locus Biosciences. He holds a B.A. from the University of Tennessee and FINRA Series 62, 63, 65 licenses.

aw@av.co

Henry Klingenstein· Partner· San Francisco, California, United Statesin

Frontier technology investor focused on healthcare, fintech, and consumer. He previously incubated Spur Labs, worked at ARTIS portfolio company Quid, and was a fellow at Longitude Capital. He holds an MBA from Stanford GSB and an AB from Harvard.

hk@av.co

Omair Khan· Partner· San Francisco, California, United Statesin

Partner focused on early-stage investments in frontier technologies advancing the human condition, with physician-scientist training spanning clinical medicine, biomedical research, global health, and policy. He completed his BS at Yale and is a Paul & Daisy Soros Fellow.

ok@av.co

Stuart Peterson· Managing Partner· San Francisco, Californiain

Founder and Managing Partner of ARTIS, recognized on the Forbes Midas List and as a TechCrunch VC of the Year finalist. His investments include StemCentrx, YouTube, Palantir, Cohesity, and numerous life sciences companies, and he cofounded FIG (Food is Good) and Onto Health.

sp@av.co

Niraj Mehta· Venture Partner· Stanford, California, United Statesin 𝕏

Partner focused on sourcing, diligencing, and supporting therapeutics companies, holding five board seats across the portfolio. A former ARTIS Fellow, he holds a PhD in Chemistry from Stanford and a BS in Chemical Engineering from UCLA.

nm@av.co

Alicia D'Souza· Senior Fellowin

Cameron Walker· Senior Fellow

Danilo Dubocanin· Senior Fellowin

Kamal Obbad· Senior Fellowin

Ramtin Talebi· Senior Fellowin

Vivian Utti· Senior Fellow

AJ Phillips· Fellowin

ARTIS Fellow and PhD candidate in Electrical Engineering at Stanford in the Chichilnisky Lab, working on brain-computer interfaces for vision restoration and an NSF Graduate Research Fellowship recipient.

Al Mezzaroba· Pioneer

ARTIS Pioneer, a lawyer by training and former president and CEO of Lower Bucks Hospital, with over two decades of operations and management experience in payer and hospital systems.

Alex Real· Investorin

MD-PhD investor focused on healthcare and life sciences companies. He trained as a physician-scientist with degrees from Stanford, an MD from Icahn School of Medicine at Mount Sinai, and radiation oncology residency at UCSF, and was formerly a professional ballet dancer.

Alexandra· Fellow

ARTIS Fellow and Bioengineering PhD student at the University of Pennsylvania developing cancer immunotherapies, previously a life science strategy consultant at Kx Advisors, with a degree in Biological Engineering from MIT.

Andrew· Fellow

ARTIS Fellow and MD candidate at Weill Cornell Medicine and biomedical engineer developing minimally invasive cardiac devices. He founded the healthtech newsletter Future Human and co-led the Helix Healthcare Incubator.

Anjali· Fellow

ARTIS Fellow and Cardiology fellow at Johns Hopkins with an MD/MBA from Penn and Wharton, interested in the intersection of population health, health policy, and digital health innovation.

Ann Lee-Karlon· Pioneer

Bioengineer turned biotech operator who spent 18 years at Genentech before becoming COO and employee #2 at Altos Labs. She serves on the board of ARTIS portfolio company Eko.

Ann Marie· Fellowin

ARTIS Fellow and dual MD/MBA candidate at Duke, previously a venture capital associate at the Oklahoma Life Science Fund, focused on expanding access to and affordability of care.

Areeba· Fellow

ARTIS Fellow and Emergency Medicine resident at Stanford Healthcare with an MD from Emory and biomedical/software engineering training from Georgia Tech, having worked as a biomedical engineer and a software engineer on ML tools at Google.

Austin Landgraf· Fellowin

ARTIS Fellow and MD-PhD candidate at Albert Einstein College of Medicine, with research integrating genomics, proteomics, and metabolism, and prior drug discovery work at FibroGen and BioMarin.

Bahija Jallal· Pioneer

ARTIS Pioneer, former President of MedImmune and current CEO of Immunocore, and one of few women to lead a company to IPO, emphasizing the coupling of science with strategy and vision.

Bill Carson· Pioneer

ARTIS Pioneer and psychiatrist by training with expertise in regulatory compliance and FDA approvals, having brought drugs such as Abilify, Rexulti, Jynarque, and the first FDA-approved digital medicine Abilify MyCite to market at Otsuka.

Cheng Kai Lim· Fellow

ARTIS Fellow and PhD-MBA student at the National University of Singapore working on synthetic biology and DNA data storage, and former Global Chair of iGEM's entrepreneurship programme.

Coco Bryant· Entrepreneur in Residence (EIR)

Physician with clinical experience across oncology, gastroenterology, vascular surgery, and emergency medicine, bringing a patient-centered lens and molecular research background to biotech investing. She earned honors in biomedical research at the University of New South Wales.

Collin· Fellow

ARTIS Fellow and PhD candidate in Biomedical AI at Mount Sinai developing machine learning methods for single-cell and spatial biotechnologies, and co-founder of Nucleate NYC and Nucleate Policy.

Craig Herkert· Pioneer

ARTIS Pioneer and global retail executive with expertise in the supermarket industry, formerly CEO of Walmart Americas and Supervalu, currently Interim CEO of Save a Lot and an adjunct professor at the University of St. Thomas.

David Bunn· Fellowin

ARTIS Fellow, internal medicine resident at Brigham and Women's Hospital and MBA candidate at Harvard Business School, with research at the intersection of cardiology, health policy, and digital innovation, and co-founder of Aidra Health.

Kash Chandarana· Pioneer

ARTIS Pioneer and co-founder of Luxe Brand Assets and Alma Hotel Management with 30+ years in hotel and real estate investment management. He served on the Council of the London School of Hygiene and Tropical Medicine for over 15 years.

Leena Das-Young· Pioneer

ARTIS Pioneer providing consulting to the biopharma and healthcare investment space, drawing on a 15+ year pharma and diagnostics career including roles as GM & Chief Lunar Officer at Guardant Health and VP of Late Phase Strategy in Oncology at Pfizer.

Megan Daugherty· Chief of Staffin

Chief of Staff with over 10 years of event planning and guest relations experience, having previously worked at top Northern California hotels and restaurants including the Ritz-Carlton Half Moon Bay and Michelin-starred establishments.

Michael Yang· Operating Partner· Palo Alto, Californiain 𝕏

Operating Partner with a career in pharmaceutical leadership, including President of CNS and Immunology at Janssen, Chief Commercial Officer at ACADIA Pharmaceuticals, and President and CEO of ViaCyte, which he led through its acquisition by Vertex Pharmaceuticals.

myang@omersventures.com

Prashant Mali· Pioneer

ARTIS Pioneer and bioengineering faculty member at UC San Diego working in synthetic biology and regenerative medicine, and scientific co-founder of Shape Therapeutics, Navega Therapeutics, Boundless Biosciences, and Seven Therapeutics.

Raghav Chari· Pioneer

ARTIS Pioneer who spent 10 years at Dr. Reddy's Laboratories, including as President of Promius Pharma, and currently serves as Chief Innovation Officer at Covis Pharma, bringing pharma and drug translation expertise.

Richard Daniels· Pioneer

ARTIS Pioneer and former CIO of Kaiser Permanente, with prior IT transformation leadership at CapitalOne and JPMorgan Chase. He serves on the boards of Silicon Valley Bank, Fastly, and CSAA Insurance Group and was named to the CIO Hall of Fame in 2019.

Richard Fuchs· Pioneer· Laguna Beach, California, United Statesin

ARTIS Pioneer and CEO of Opyn. Formerly SVP of Strategy, Sales and Innovation at Walmart Health & Wellness and a 10-year veteran of Elevance Health (formerly Anthem), he brings extensive experience in growth strategy and payer relationships.

Sara Kenkare-Mitra· Pioneer

President and Head of R&D at Alector after 23 years at Genentech, focused on treatments for neurodegeneration. She holds a PhD in Pharmaceutical Chemistry from UCSF and was named one of 2018's Fiercest Women in Life Sciences.

Simon Helfgott· Pioneer

ARTIS Pioneer, practicing rheumatologist and Head of Education at Brigham and Women's Hospital at Harvard Medical School, bringing rheumatology and autoimmune expertise.

Thomas Lönngren· Pioneer

ARTIS Pioneer, Strategic Advisor at NDA Group and Director at Pharma Executive Consulting, who ran the European Medicines Agency as Executive Director from 2001 to 2010, offering deep regulatory expertise.

Wendy Mayer· Pioneer

ARTIS Pioneer and VP of Performance Management and Strategic Projects within HR at Pfizer, with 20+ years at Pfizer across strategy, market access, sales leadership, and analytics roles.

Zain Kassam· Pioneer (ARTIS Pioneers Program)· Somerville, Massachusetts, United Statesin

Zain Kassam is a physician trained in gastroenterology whose work centers on the gut microbiome, combining clinical GI, biostatistics, and engineering. He studied health sciences at McMaster, trained in medicine at Western University and in Internal Medicine and Gastroenterology at McMaster, earned an MPH in quantitative methods at Harvard's T.H. Chan School of Public Health, and completed a postdoctoral fellowship in microbiome engineering at MIT. He co-founded and served as CMO of OpenBiome and of Finch Therapeutics, and is currently CMO at Seed Health; he participates in Artis Ventures' Pioneers Program.

Robert Riemer· Chief Operating Officer and Chief Compliance Officer

COO and Chief Compliance Officer with ARTIS for over 10 years. Previously COO of Fort Point Capital, Controller of Blum Capital Partners, and Corporate Finance Officer of Merritt Capital. He holds an accounting degree, is a CPA, and earned a JD from DePaul University College of Law.

Founder mafia

4 people who came through Artis Ventures went on to found or lead other companies.

Paul JohnsonOperating PartnerFounded Pauljohnson +1 Zain KassamPioneer (ARTIS Pioneers Program)Founded Finch Therapeutics +1 Stuart PetersonManaging PartnerFounded Artis Ventures Jeffrey B. KindlerVenture PartnerFounded Centrexion Therapeutics

What they invest in

from 66 of 83 portfolio companies

Healthtech ×32Biotech ×29Digital Health ×21Medical Devices ×21AI & Machine Learning ×19Deep Tech ×11SaaS ×8Enterprise Software ×6

HQs:United States×46United Kingdom×3Germany×1India×1

Who they back

founder profiles across 45 portfolio companies

16%

solo founders

7 of 45 mapped founding teams

47%

repeat founders

of 58 founders with career history

~3 yrs

old at investment

median across 24 dated deals

Founding team size:solo founder×72 founders×143 founders×114+ founders×13

Where their founders studiedfrom 56 founders with education data

Harvard University ×4University of California, Berkeley ×4Massachusetts Institute of Technology ×3Stanford University Graduate School of Business ×3Dartmouth College ×2Heidelberg University ×2Indian Institute of Technology, Kharagpur ×2McGill University ×2

What their founders studiedfrom 56 founders with field-of-study data

Life Sciences ×17Engineering ×14Computer Science ×11Business & Management ×6Chemistry ×6Medicine ×4Economics ×3Mathematics & Statistics ×3

Where their founders worked beforefrom 58 founders with career history

Stanford University ×5Google ×3Adentro ×2Doblet ×2Juniper Networks ×2NeueHouse ×2TMRW Life Sciences ×2United States Marine Corps ×2

Accelerator rootsportfolio companies that came through a program

Y Combinator ×3

23 founders hold a PhD · 3 hold an MBA (of 59 with degree data)

Investments · 83 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 3 2024 · 3 2023 · 9 2022 · 4 2021 · 5 2020 · 4 2019 · 2 2018 · 2 2017 · 2 2016 · 1 2015 · 138 dated

AbbVieNYSE: ABBVApr 2016

AbbVie develops and sells biopharmaceutical therapies across immunology, neuroscience, oncology, and aesthetics, addressing autoimmune diseases, neurologic conditions, blood cancers, and cosmetic applications through products like Skyrizi, Rinvoq, Humira, Vraylar, Imbruvica, and Botox.

BiotechNorth Chicago, US

Thomas A. Hurwich(Executive Officer)Timothy J. Richmond(Executive Officer)Henry Gosebruch(Executive Officer)inAzita Saleki-Gerhardt(Executive Officer)inMichael E. Severino(Executive Officer)William Chase(Executive Officer)

Partner Stuart Peterson· quoted

Co-investorsFounders Fund

Bloom Energybloomenergy.com in 𝕏NYSE: BE

Bloom Energy manufactures solid oxide fuel cell systems for onsite power generation at commercial, industrial, and data center facilities.

CleantechEnergyHardware

K.R. Sridhar(Founder, Chairman, and CEO)KR Sridhar, PhD(Founder, Chairman and Chief Executive Officer)K. R. Sridhar(Founder)KR Sridhar(Founder)

Co-investorsAlumni Ventures ATEL Ventures Constellation Technology Ventures Dag Ventures Enerdigm Ventures G Squared +10 more

Freenomefreenome.com in 𝕏NASDAQ: FRNMSeries B · Oct 2015 · $160M

Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, US

Riley Ennis(Founder)inCharles Roberts(Founder)inGabriel Otte(Founder)inAdam Stone(Chief Executive Officer and Director)Michael Altman(Chief Business Officer and Director)Shmuel (Sam) M. Cohn(Chief Financial Officer)

Co-investorsRA Capital Agent Capital AME Cloud Ventures Andreessen Horowitz Asset Management Company Averin Capital +15 more

Palantir Technologies Inc.palantir.com inNASDAQ: PLTR

Palantir builds data integration and analysis platforms — Gotham for defence and government, Foundry for commercial operations — and deploys forward engineers inside customer organisations.

Palo Alto, US

Peter Thiel(Founder)in Stephen Cohen(Founder)Nathan Gettings(Founder)Joe Lonsdale(Founder)inAlexander C. Karp(Founder)Alex Karp(Founder)

Co-investors137 Ventures 8VC A*AiSprouts VC Akkadian Ventures Allied Venture Partners +72 more

Affect Therapeuticsaffecttherapeutics.com in 𝕏Jul 2023 · $16M✓ verified

Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.

Digital HealthHealthtechMental HealthNew York, US

Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in

Board Kevin Ryan(Director)in Jeff Rinehart(Director)in

Co-investorsCity Light AlleyCorp Kapor Capital LifeArc Ventures Mana Ventures Samsung Next +2 more

Locus Bioscienceslocus-bio.com in 𝕏Nov 2017 · $19M✓ verified

Locus Biosciences develops engineered bacteriophage therapies for treating bacterial infections and conditions in immunology, oncology, and CNS disorders.

AI & Machine LearningBiotechDeep TechHealthtechRaleigh, US

Paul Garofolo(CEO & Co-founder)NICK TAYLOR(Executive Officer)in Nick Conley(Vice President of Technology (Co-founder of EpiBiome, acquired by Locus))in

Board GEOFFREY GLASS(Director)inDAVID JOHNSTON(Director)BARY BAILEY(Director)

Co-investorsAbstract Ventures Hemisphere Ventures LLC Domain Associates Longitude Capital Starlight Ventures Tencent Holdings

Outpace Biooutpacebio.com inJul 2024✓ verified

Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.

BiotechDeep TechMedical DevicesSeattle, US

Marc Lajoie(Founder)in Scott Boyken(Founder)inStanley Riddell(Co-Founder and Scientific Advisor)Aaron Foster(Executive Officer)inCharity Scripture(Executive Officer)in Eric Soller(Executive Officer)in

Co-investorsRA Capital Abstract Ventures ATEL Ventures Atinum Investment Co. Ltd.Civilization Ventures Management, Llc Mana Ventures +8 more

Valarianvalarian.com in✓ verified

Valarian builds ACRA, an infrastructure platform for organizations requiring high levels of control, privacy, and compliance in their digital environments.

Cloud ComputingCybersecurityEnterprise SoftwareLondon, GB

Max Buchan(Co-founder & CEO)inJosh McLaughlin(Co-founder & COO)

Co-investorsIQ Capital Molten Ventures New Enterprise Associates (NEA)Scout Ventures Lightbank Founders Factory +6 more

Versaversa-networks.com in 𝕏Oct 2022✓ verified

Versa Networks provides SASE (Secure Access Service Edge) solutions that integrate security, networking, and analytics via cloud and on-premises platforms for enterprises and service providers.

Cloud ComputingCybersecurityEnterprise SoftwareSanta Clara, US

Apurva Mehta(Founder)in Kumar Mehta(Founder)inJoaquin Rodriguez Torres(Director)Kelly Ahujain Lalit Kumar(Executive Officer)in

BoardJim Goetz(Director)

Co-investorsSequoia Capital Comcast Ventures B Capital Mayfield Fund RPS Ventures Atlantic Vantage Point +2 more

Conceivable Life Sciencesconceivable.life inSeries A · Sep 2025 · $50M

Conceivable builds AURA, a robotic automation platform that automates manual IVF laboratory procedures using physical AI, aiming to increase accessibility and affordability of in-vitro fertilization treatments.

AI & Machine LearningDeep TechHealthtechMedical DevicesRoboticsNew York, US

Alan Murray(Founder & CEO)in Alejandro Chavez-Badiola(Founder & Chief Medical Officer)in Joshua Abram(Founder)in

BoardAike Ho(Director)Fred Destin(Director)

Board seat Stuart Peterson· per SEC Form D

Co-investorsACME Capital Advance Venture Partners Future Positive Capital Muse Capital Time BioVentures

Excision BioTherapeutics Inc.excisionbio.comSeed · Feb 2021 · $10M

BiotechSan Francisco, US

Daniel Dornbusch(Executive Officer, Director)

Board Ashok Krishnamurthi(Director)inWilliam Carson(Director)

Board seat Vasudev Bailey· per SEC Form D

Co-investorsAlumni Ventures Anzu Partners Cota Capital Olive Tree Capital Adjuvant Capital GreatPoint Ventures

OverT Bioovert.bio inSeed · Apr 2023 · $16M

Overt Bio develops cell therapies that link genes to immune functions using genome-scale discovery platforms.

AI & Machine LearningBiotechMedical DevicesNew York, US

Dr. Legut(Co-Founder and CEO)Dr. Sanjana(Co-Founder)Mateusz Legut(Executive Officer, Director)Neville Sanjana(Director)Mat Legut(Founder)in

Board seat Vasudev Bailey· per SEC Form D

Co-investorsCivilization Ventures Management, Llc Fusion HAWKTAIL Wing Alexandria Gaingels +1 more

Transparent Health Marketplace inApr 2021 · $30M

HealthtechWest Palm Beach, US

Randy Beckham(Executive Officer)Eric R. Hanson(Executive Officer, Director)Charles Middleton(Executive Officer)Edward Hammel(Executive Officer)Michael Josephs(Executive Officer)David Saloff(Executive Officer, Director)in

Board seat Stuart Peterson· per SEC Form D

Unnatural Productsunnaturalproducts.com in 𝕏Seed · Sep 2019 · $6M

Unnatural Products is a drug discovery platform company that develops synthetic macrocycles to target previously undruggable disease targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSanta Cruz, US

Cameron Pye(Co-Founder & CEO)inJoshua Schwochert(Co-Founder & CSO)in

Board seat Vasudev Bailey· per SEC Form D

Co-investorsAbstract Ventures Asset Management Company Better Ventures Central Llc Blue Bear Ventures Colorcon Ventures Droia Ventures +8 more

Activ Surgicalactivsurgical.com in 𝕏Jul 2020 · $15M

Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye.

AI & Machine LearningHealthtechMedical DevicesBoston, US

Peter Kim(Founder)inMichael Ruehlman(Executive Officer)in Todd Usen(Executive Officer, Director)in

BoardEmily Casey(Director)Ashok Krishnamurthi(Director)inDavid Wells(Director)

Co-investorsReimagined Ventures Alumni Ventures Basecamp Fund Castor Ventures Cota Capital Dns Capital +8 more

Aether Bioaetherbio.com in 𝕏

Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.

Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials

Pavle Jeremic(Founder & CEO)in Jay Zaveri(Co-Founder & President)

Co-investors4DX Ventures Abstract Ventures Blue Bear Ventures BoxGroup Calm Ventures Evolution VC Partners +12 more

All in Bioallinbio.com

ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases.

BiotechHealthtechMedical Devices

Co-investors+ND Capital

Ark PESarkpes.com

Ark provides a customizable digital platform for venture capital and private equity firms to manage investor communications, performance reporting, and document sharing with their limited partners.

Enterprise SoftwareFintechSaaS

Co-investorsAcies Investments Aloft VC Alta Partners Amity Ventures Asymmetric Capital Partners At One Ventures +21 more

Arkenstone Defensearkenstonedefense.com in

Removing execution friction between modern technology companies and the U.S. national security ecosystem

Menlo Park, US

Rachel Olney(Director and Secretary)in Peter Dixon(Director and Chief Executive Officer)in William Treseder(Director, Chief Financial Officer and Treasurer)in

Co-investorsEvolution VC Partners ForgePoint Capital J2 Ventures Tau Ventures

Arubaarubanetworks.comacquired by Hewlett-Packard · Mar 2015 · $3B

Enterprise networking (Wi-Fi, switches, SD-WAN) with cloud-managed security for campuses & branches

Keerti Melkote(Founder)Pankaj Manglik(Founder)

Co-investorsAmplify Partners Asset Management Company Cervin Golub Growth ICCP Venture Partners iGlobe Partners +12 more

Bettani Farmsbettani.com in

Bettani produces dairy-free cheese using a proprietary plant-based protein derived from regenerative crop seeds, offering products with comparable taste, texture, and protein content to conventional dairy cheese.

CleantechFoodTechImpact & Social Good

Co-investorsManta Ray Ventures S2G Investments Gratitude Railroad

Cartography Biosciencescartography.bio in 𝕏Oct 2025 · $67M

Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.

AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US

Max Mumbach(Founding Scientist, Target Discovery)inJeffrey Verboon(Founding Scientist, Computational Biology)inAnsu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Founder)in

Co-investors8VC Andreessen Horowitz Catalio Capital Management, LP Finchley Healthcare Ventures Global BioAccess Fund HAWKTAIL +9 more

Climax Foodsclimax.bio inSep 2020 · $7.5M

Climax (Bettani) develops dairy-free cheeses that match the taste, texture, melt and stretch of dairy cheese while providing 80–100% of the protein.

BiotechClimate TechFoodTech

Co-investorsAt One Ventures Untapped Ventures Valor Equity Partners Canaccord Genuity Group Climate Capital Global Founders Capital +6 more

Cohesitycohesity.com in 𝕏Jun 2018 · $250M

Cohesity provides cyber resilience software that helps organizations identify and protect the minimal critical datasets and systems needed to restart operations after ransomware attacks or disasters.

Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareSan Jose, US

Mohit Aron(Founder)in Sanjay Poonen(CEO and President)inTIMOTHY ROBBINS(Executive Officer)inLORENZO MONTESI(Executive Officer)inROB SALMON(Executive Officer)inSanjay Poonen (CEO)(Founder)

Co-investors3Spoke Capital Accel Adit Ventures Management, Llc Battery Ventures Cisco Investments Coatue Management +26 more

Curegetcure.app in

CURE operates a booking platform that connects pharmacies with delivery service partners to generate online orders.

B2B MarketplacesHealthtechSaaSBerlin, DE

Manuel Aberle(Founder)in

Co-investorsAbstract Ventures FJ Labs J12 Ventures Stella Capital Accel Accomplice +23 more

Delfinadelfina.com in 𝕏Jan 2025 · $17M

Delfina provides a pregnancy support app, including a "Delfina Doula" feature, that lets pregnant people share symptoms and health data such as blood pressure with their providers between appointments.

Digital HealthFemTechHealthtechSan Francisco, US

Senan Ebrahim(Founder)in Isabel Fulcher(Director)inAli Ebrahim(Founder)Priyanka Vaidya(Founder)

Board Dafina Toncheva(Director)in Jacob Yormak(Director)in

Co-investorsBoutique Venture Partners Bread And Butter Ventures, Llc Matchstick Ventures SemperVirens Venture Capital SpringTime Ventures Story Ventures +7 more

Delixdelixtherapeutics.com inSeries A · Sep 2021 · $70M

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsBailey Venture Partners Casa Verde Capital Dolby Family Ventures Noetic OMX Ventures Palo Santo VC +7 more

Doctronicdoctronic.ai in 𝕏

Doctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians.

AI & Machine LearningDigital HealthHealthtech

Matt Pavelle(Founder)inDr. Adam Oskowitz(Founder)inAdam Oskowitz(Founder)Adam Oskowitz Matt Pavelle(Founder)

Co-investorsAbstract Ventures Lightspeed Venture Partners PID Fund I, a series of DV Collective, LP Seven Stars Ventures Transpose Platform Management Tusk Venture Partners +5 more

Ekoeko.in in 𝕏Feb 2023 · $65M

Eko provides digital banking and financial services to underserved populations in India through a network of merchant business correspondents and an open API platform.

B2B MarketplacesDeveloper ToolsFintechSaaS

Abhinav(Co-founder)Abhishek(Co-founder)

Co-investorsCreation Investments Capital Management Questa Capital DigiTx Partners LLC Highland Capital Partners LG Technology Ventures

Ekoeko.comFeb 2023 · $65M

Eko provides AI-driven tools to generate customizable lifestyle imagery and graphics for e-commerce from a single product capture, enabling businesses to create varied assets without additional photo shoots.

AdTechAI & Machine LearningE-commerceRetail Tech

Yoni Bloch(Founder)

Co-investorsMarker Agaeti Ventures Better Ventures Central Llc DigiTx Partners LLC East Ventures Highland Capital Partners +6 more

Eko Healthekohealth.com in 𝕏Series A · Mar 2018 · $5M

Eko develops FDA-cleared digital stethoscopes and AI-powered software that enables healthcare professionals to detect and diagnose cardiovascular disease with greater accuracy.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Connor Landgraf(Co-Founder and CEO)inTyler Crouchin Jason Bellet(Co-Founder and Chief Business Officer)in

Co-investorsQuesta Capital Highland Capital Partners Better Ventures Central Llc CAL Innovation California Innovation Fund DigiTx Partners LLC +14 more

Enkluenklu.comJun 2019

Enklu develops Verse, a location-based attraction platform for venue, resort, and entertainment center operators to create social entertainment experiences.

GamingAlameda, US

Raymond Kallmeyer(Founder)in

Co-investorsBrinc Espt Ventures Llc IrishAngels Motivate Venture Capital

Fabric Genomicsfabricgenomics.com in 𝕏

Fabric Genomics provides an AI-based platform for next-generation sequencing (NGS) analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOakland, US

Martin Reese(Co-Founder, President, and CEO)inMartin Reese, Ph.D.(Co-Founder, President, and CEO)Erwin Frise(Vice President of Technology and Data Science)in

Co-investorsForesite Capital Mighty Capital Casdin Capital

Fig Appfoodisgood.com in

Fig is an app that helps users with dietary restrictions (gluten-free, food intolerances, ingredient avoidance) discover foods and products that match their dietary needs.

ConsumerHealthtechNew York City, US

Andrew Hollar(Founder)in Jake Lynch(Founder)in

Co-investorsAllerfund Ventures, Llc Streamlined Ventures

Glyphicglyphic.ai

AI copilot for sales teams analyzing customer interactions and optimizing revenue strategies

Adam Liska(Founder)Devang Agrawal(Founder)

Co-investorsFJ Labs Point72 Ventures Atlassian Ventures Creator Fund DN Capital Framework Venture Partners +1 more

Glyphic Biotechnologiesglyphic.bio in 𝕏Feb 2024

Glyphic Biotechnologies develops ProSE™, a high-throughput de novo protein sequencing technology for analyzing proteomes with single-molecule sensitivity.

BiotechDeep TechBerkeley, US

Daniel Estandian(Founder)inEd Boyden(Founder)Josh Yang(Founder)inJoshua Yang(Founder)

Board Craig Asher(Director)in Jimmy Yun(Director)in

Co-investorsBlack Flag Civilization Ventures Management, Llc FoundersX Ventures Harpoon Ventures In-Q-Tel LongeVC +9 more

IDbyDNAillumina.comJan 2020 · $20MAcquired

Scalable, high throughput DNA sequencing platforms.

Co-investorsARCH Venture Partners Hemisphere Ventures LLC Heran Partners SPRINGROCK VENTURES Venrock Genesys Capital

Inceptiveinceptive.life inSep 2023

Inceptive builds foundation models of biological systems for drug discovery, specializing in sequence-based medicines like mRNA and peptides.

AI & Machine LearningBiotechMedical DevicesPalo Alto, US

Jakob Uszkoreit(Founder)in Kevin Heyries(Executive Officer)inDiana Isabel Ajuria(Executive Officer)Do Soon Kim(Executive Officer)inJakob Uszkoreit Rhiju Das(Founder)Rhiju Das(Founder)

Co-investorsAndreessen Horowitz Obvious Ventures S32 Section 32 NVentures NVIDIA

Lemonaidlemonaidhealth.comJul 2020acquired by 23andMe

Lemonaid Health is a telehealth company that lets patients access medical care and treatment online from home, including services like contraceptive pill prescriptions and UTI treatment.

ConsumerDigital HealthDirect to ConsumerHealthtechSan Francisco, US

Paul Johnson(Founder)in

Co-investorsCivilization Ventures Management, Llc Correlation Ventures Daybreak Partners eGateway Capital Firebolt Ventures Management Company, Llc Health Velocity Capital +6 more

Luminateluminatemed.com in 𝕏Series A · Jan 2026 · $21M

Luminate develops medical device technology to address chemotherapy side effects, particularly hair loss and peripheral neuropathy, for oncology patients and healthcare providers.

BiotechDigital HealthHealthtechMedical DevicesGalway, US

Aaron Hannon(Founder)in Barbara Oliveira(Founder)inProf. Martin O'Halloran(Co-Founder)JAMES EVERINGHAM(Executive Officer, Director)Eldad Livni(Founder)Leonid Belkind(Founder)

Co-investorsSciFounders Y Combinator 8VC Atlantic Bridge Ventures Faber Metaplanet +12 more

Meomindmeomind.com in 𝕏

Meomind provides personalized, evidence-based psychotherapy accessible on demand 24/7 through digital platforms.

AI & Machine LearningDigital HealthHealthtechMental Health

Sushant Gupta(Founder)inMakan Amini(Founder)

Co-investorsFusion Z21 Ventures

Metriportmetriport.com in 𝕏

Metriport provides an open-source API for retrieving and exchanging clinical data.

AI & Machine LearningCloud ComputingData & InfrastructureDeveloper ToolsDigital HealthHealthtechSan Francisco, US

Dima Goncharov(Founder)in Colin Elsinga(Founder)inDima Goncharov Colin Elsinga(Founder)Melissa Lieb(Recruiter)Ray Pelegrino(Founding Recruiter)Danny Lebovitz(Chief of Staff)

Co-investorsVentureSouq Y Combinator CRV (Charles River Ventures)Innovation Endeavors Matrix MyAsiaVC +5 more

Modern meadowmodernmeadow.com in 𝕏

Modern Meadow develops animal-free, bio-fabricated leather alternatives using synthetic biology and material science for the fashion, interiors, and automotive industries.

BiotechCircular EconomyNew MaterialsPine Brook, US

Gabor Forgacs(Founder)inFrancoise Marga(Founder)inKaroly Jakab(Founder)in Anna Bakst(Executive Officer, Director)inRex Liu(Executive Officer)David Williamson(CEO)in

Co-investorsAstanor Ventures Breakout Labs Breakout Ventures Collaborative Fund Horizons Ventures Inventus Capital Partners +7 more

Mytosmytos.bio in 𝕏Sep 2023

Mytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.

Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB

Ali Afshar(CEO)in Ignacio Willats(Founder)inHenry Miskin(Developer)James Cunningham(Hardware Design Engineer)Jack Owen(Operations)Sam O'Mahony(Senior Electronics Engineer)

Co-investorsY Combinator Acequia Capital (AceCap)Deep Science Ventures Emles Venture Partners IQ Capital Jude Gomila +12 more

Network Bionetwork.bio inPre-Seed · Sep 2022 · $3M

Network Bio activates biobanks through securitization and capital infusion, providing research-grade data assets and operational infrastructure for precision medicine and biomedical research.

BiotechData & InfrastructureDigital Health

Co-investorsBreyer Capital Founders Fund S32

Nimble Storagenimblestorage.com

Umesh Maheshwari(Founder)in

Co-investorsAccel Glynn Capital Management Lightspeed Venture Partners Notable Capital Sequoia Capital Wing

Nimble Storagehpe.comAcquired

HPE subsidiary building all-flash and hybrid flash storage arrays with InfoSight predictive analytics for data centers.

Spring, US

Suresh Vasudevan(Founder)Suresh Vasudevan (CEO)(Founder)Umesh Maheshwari(Founder)Varun Mehta(Founder)

Co-investorsAmplify Partners Asset Management Company iGlobe Partners Kleiner Perkins Menlo Ventures New Enterprise Associates (NEA)+7 more

ONIoni.bio in 𝕏Series B · Jan 2022 · $75M

ONI develops the Nanoimager, an automated super-resolution imaging system.

BiotechDeep TechHardwareMedical DevicesOxford, GB

Co-investorsAnjost ARCH Venture Partners Future Planet Capital Oxford Technology Management Vertical Venture Partners Axon Ventures +6 more

Onto Fertilityonto.health in

ONTO Health provides personalized fertility, hormone, and longevity care for patients at various stages of reproductive health, combining evidence-based medicine with diagnostics and wellness therapies.

Digital HealthFemTechHealthtechLongevityWellness & Fitness

Dr. Roohi Jeelani(REI, OB/GYN)

Co-investorsCortado Ventures Revolution The Council

Opynopynhealth.com in

Opyn provides a healthcare technology platform that unifies benefits, care navigation, virtual care, price transparency, provider intelligence, and service automation for health plan members, providers, and the administrative teams that support them.

AI & Machine LearningDigital HealthHealthtechSaaS

Co-investors1kx A.Capital Ventures CoinFund DTC Capital Paradigm Uncorrelated Ventures +1 more

Ozlo Sleepozlosleep.com in 𝕏Series A · Aug 2023 · $10M

Ozlo manufactures sleep wellness products including blackout sleep masks and audio devices designed to improve sleep quality through light and sound control.

ConsumerHardwareWellness & Fitness

Co-investorsLifeArc Ventures WSS

Powerwithpower.com

Power builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment.

Digital HealthHealthtech

Brandon Li(Founder)Michael Gill(Founder)

Co-investorsContrary CRV (Charles River Ventures)Kin Ventures Anthemis Venture Dash Fund First Circle +3 more

Practice Fusionpracticefusion.com in 𝕏Sep 2013 · $70M

Practice Fusion provides a cloud-based electronic health record (EHR) platform with integrated medical billing services and e-prescribing for independent medical practices.

Digital HealthHealthtechSaaSSan Francisco, US

Ryan Howard(Executive Officer, Director)in

BoardMark Goines(Director)Beth Seidenberg(Director)inMichael Harden(Director)Cora Tellez(Director)

Co-investorsBand of Angels Canvas Ventures Longitude Capital Deerfield Management Company Felicis Ventures Founders Fund +6 more

Quidnetbasequid.com

NetBase Quid offers an AI-powered consumer and market intelligence platform that analyzes large volumes of unstructured external data—social media, news, reviews, patents, and broadcast—to surface trends, brand sentiment, and competitive insights.

AI & Machine LearningData & InfrastructureMarketing Tech

Co-investorsAtomico In-Q-Tel

Rad AIradai.com in 𝕏

Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows.

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSan Francisco, US

Dr. Jeff Chang(Co-founder)in Doktor Gurson(Founder)inJeff Chang(Founder)

Board Stuart Peterson(Director)in Bruce Armstrong(Director)in

Co-investorsAlpha Partners Array Ventures Management Llc City Light Corewell Health Ventures Crosscourt Ventures Esplanade Ventures +12 more

Range Biotechnologiesrange.bio inSeed · Jun 2023 · $5.2M

Range Bio (Range Biotechnologies) develops next-generation diagnostics using translational proteomics for applications in human health.

BiotechHealthtechMedical Devices

Brandon Wilson, Ph.D.(Co-founder & CEO)Brandon Wilson(Founder)inNicolo Maganzini(Founder)Tom Soh(Founder)

Co-investorsCivilization Ventures Management, Llc Fifty Years HAWKTAIL Page One Ventures Pear VC Pillar VC

Replayreplayjeans.com

Replay is an Italian denim and apparel brand selling jeans and fashion items directly to consumers, with localized pricing, currency, and shipping by country.

ConsumerDirect to ConsumerE-commerce

Claudio Buziol(Founder)

Replay Therapeuticsreplay.bio

Replay develops gene therapies for patients with rare genetic diseases.

BiotechHealthtechLongevity

Lachlan MacKinnon(CEO and Founder)Adrian Woolfson(Founder)Robert Coffin(Executive Chairman)Maria Castner-Miller(General Counsel)inRenata Martin(VP & Head of Gene Therapy)inSaurabh Sharma(VP & Head of CMC)

Co-investorsOMX Ventures Solari Capital Axial VC

RightSiterightsitehealth.com in

RightSite Health provides emergency medical services (EMS) support by connecting emergency room doctors with EMS crews to assess and redirect low-acuity patients, and deploys patient navigators to address underlying clinical and social needs that drive unnecessary emergency calls.

Digital HealthHealthtechSaaSSan Antonio, US

Matthew Sedgwick(Executive Officer)inMichael Boxer(Executive Officer, Director)inJames M.O. Rubin(Executive Officer, Director)

Board Richard Lungen(Director)inGary Swart(Director)

Co-investorsHC9 Ventures Virtue Ventures

Science Corporationscience.xyz

Science Corporation develops brain-computer interface and neural engineering technology to restore vision, cognition, and mobility to patients with debilitating conditions.

AI & Machine LearningBiotechDeep TechDigital HealthMedical DevicesAlameda, US

Max Hodak(Founder)inAlan Mardinly(Founder)

Co-investors885 Capital age1 Avalanche VC Beyond Capital Conversion Capital Duke Capital Partners +15 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AffectCerebral Exonics TherapeuticsFood Is Good (FIG)Onto HealthPi BioPioneersPower Life Sciences StringifyVersa Networks

Exits · 9

4 IPOs · 5 acquisitions · showing 6

AbbVieNYSE: ABBVBloom EnergyNYSE: BEFreenomeNASDAQ: FRNMPalantir Technologies Inc.NASDAQ: PLTRArubaacq. by Hewlett-PackardLemonaidacq. by 23andMe

Portfolio news

latest coverage across their companies

NetBase Quid Revenue 2021: $30M Est. ARR, $42.9M Raised

Quid · getlatka.com · Sep 5, 2026

Cohesity - Wikipedia

Cohesity · en.wikipedia.org · Sep 2, 2026

Metriport (S22) raises $26M to give clinicians insight into any patient question

Metriport · metriport.com · Aug 28, 2026

Valarian Raises $50 Million Series a Led by NEA to Deliver the Sovereign Infrastructure Layer for High-Consequence Operations and AI Driven Systems

Valarian · finance.yahoo.com · Jul 13, 2026

Arkenstone Defense Raises $35M in Seed Funding

Arkenstone Defense · finsmes.com · Jul 8, 2026

Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma - BioSpace

Siren Biotechnology · biospace.com · Jun 29, 2026

Cartography Biosciences Receives Investment From Samsung Ventures

Cartography Biosciences · finsmes.com · May 7, 2026

Doctronic Raises $40M in Series B Funding

Doctronic · finsmes.com · Mar 24, 2026

Frequently asked questions

How many investments has Artis Ventures made?: Artis Ventures has 83 tracked investments, 9 of which have exited, including 4 dated in the last 24 months.
What stage does Artis Ventures invest at?: Artis Ventures invests at the Seed, Series A, Series B stages.
What is Artis Ventures's typical check size?: Artis Ventures typically writes checks of $50K – $25M.
What sectors does Artis Ventures focus on?: Artis Ventures focuses on AI & Machine Learning, Biotech, Consumer, Deep Tech, Digital Health, Fintech, Healthtech, Longevity, Medical Devices.
Where is Artis Ventures located?: Artis Ventures is headquartered in San Francisco, US.
Does Artis Ventures lead rounds?: Yes, Artis Ventures leads investment rounds.
Who does Artis Ventures co-invest with?: Artis Ventures most often shares deals with Wing, Abstract Ventures, New Enterprise Associates (NEA), among 336 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Ventures #25 w/ Ameena El-Bibany - Partner @ ARTIS Ventures | BIOS

BIOS · Ameena El-Bibany

Images

Co-investors · 57

New Enterprise Associates (NEA)

New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.

Both backed · 8

Bloom Energy Eko Eko Health Nimble Storage Second Front Systems Slope Stemcentrx Valarian

$200K – $40M

Wing

Wing Venture Capital is an early-stage venture fund backing founders building the AI-first economy across infrastructure, enterprise, physical, domain-specific, security, and healthcare AI.

Both backed · 8

Aruba Cartography Biosciences Cohesity Glyphic Biotechnologies Mytos OverT Bio Unnatural ProductsNimble Storage

$200K – $20M

Founders Fund

Founders Fund is a venture capital firm that backs technology companies building transformative products.

Both backed · 7

AbbVie Palantir Technologies Inc.Network Bio Practice Fusion Seed Health Siren Biotechnology Stemcentrx

$500K – $5M

Abstract Ventures

Abstract is a San Francisco-based venture capital firm managing $1.8 billion in assets, investing in seed and early-stage companies across all sectors.

Both backed · 7

Aether Bio Cure Doctronic Locus Biosciences Outpace Bio Second Front Systems Unnatural Products

$250K – $750K

Sequoia Capital

Sequoia Capital is a venture capital firm that partners with founders to build technology companies.

Both backed · 5

Aruba Cohesity Nimble Storage Versa YouTube

$100K – $50M

RA Capital

RA Capital Management is a healthcare and planetary health investment firm that founds, funds, and scales companies using scientific diligence, multi-stage capital, and hands-on operational support.

Both backed · 4

Freenome Delix Outpace Bio ViaCyte

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.

Both backed · 3

Freenome Cohesity Luminate

$250K – $50M

Lightspeed Venture Partners

Lightspeed Venture Partners is a global venture capital firm that backs founders from Seed through Series F and beyond, emphasizing deep, immersive partnerships with the companies it invests in.

Both backed · 3

Doctronic Nimble Storage Science Corporation

$1M – $5M

Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

Both backed · 3

Cohesity Cure Nimble Storage

$500K – $100M

Notable Capital

This page announces that GGV Capital split into two separate firms in March 2024: Granite Asia (Singapore, covering APAC) and Notable Capital (US, based in Silicon Valley with offices in San Francisco and New York, investing in the US, Israel, Europe, and Latin America).

Both backed · 3

Aruba Nimble Storage Slope

$5M – $50M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

Both backed · 3

Bloom Energy Nimble Storage Practice Fusion

$500K – $15M

Cota Capital

Cota Capital is a San Francisco-based technology investment firm that invests in private and public US-based modern enterprise technology companies, offering founders operational expertise, market insights, and an industry network.

Both backed · 3

Activ Surgical Excision BioTherapeutics Inc.Seed Health

▶45 more co-investors

S32 City Light Craft Ventures Felicis Ventures Foundation Capital Battery Ventures Mayfield Fund Innovation Endeavors Sierra Ventures ARCH Venture Partners Highland Capital Partners Correlation Ventures Questa Capital Vertical Venture Partners Gradient Ventures ACME Capital Madrona Venture Group Canvas Ventures Polaris Partners What If Ventures Kickstart The Venture Collective Astanor Ventures TRANSFORMATION CAPITAL Paladin Capital Group Molten Ventures Advance Venture Partners Tencent Holdings Merck Global Health Innovation Fund Faber PsyMed Ventures Cowles Ventures Long Journey Ventures Canaan Partners Slow Ventures Physical Intelligence Thrive Capital Salesforce Ventures Unusual Ventures Digital Currency Group Polychain Capital Radical Ventures Digitalis Ventures Recode Ventures Thiel Capital

Firms observed investing alongside Artis Ventures, from public investor directories. Shared companies are the overlap with Artis Ventures's recorded portfolio.

Similar investors

GV (Google Ventures)

$250K – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.

$100K – $20M

JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm investing in early- and growth-stage companies at the intersection of technology, science, and human performance across enterprise, wellness, healthcare, and consumer markets.

$100K – $20M

Basecamp Fund

A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.

$100K – $10M

NJF Capital

NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It backs transformative entrepreneurs building industry-defining technologies with global scale potential.

Featured in lists

Investors & VC Firms in North America Seed Investors & VC Firms Investors & VC Firms in United States Series A Investors & VC Firms Seed Investors & VC Firms in North America Seed Investors & VC Firms in United States AI & Machine Learning Investors & VC Firms Fintech Investors & VC Firms Series A Investors & VC Firms in North America Healthtech Investors & VC Firms Series A Investors & VC Firms in United States AI & Machine Learning Seed Investors & VC Firms

Website & social

av.co

/3204230 @artisventures

signal ↗crunchbase ↗

As published on the firm's website.

Contact

499 Jackson Street
Suite 400
San Francisco, CA 94111
United States

Emailcontact@av.co

FoxScore

Combines investment activity, responsiveness, founder feedback, closing rate and follow-through reported by founders on Fox. Sign up to see it.

Your history

Artis Ventures isn't in your CRM yet.

+ Add to CRM

Track outreach, deck opens, and next steps across your whole raise.

✨ Smart outreach

✨ Best warm path

Funds

ARTIS Select II, L.P.vintage 2026 · 506(b)$50Mtarget

Artis Ventures III, L.P.vintage 2019 · 64 LPs · 506(b)$89.2Mraised

Artis Ventures III (Offshore), L.P.vintage 2019 · 506(b)$25Mtarget

ARTIS TECHBIO I, L.P.Mar 2026 · 102 LPs$224.4MAUM

ARTIS TECHBIO II, L.P.Mar 2026 · 61 LPs$146.7MAUM

ARTIS VENTURES II, L.P.Mar 2026 · 84 LPs$71.8MAUM

ARTIS TECHBIO II (OFFSHORE), L.P.Mar 2026 · 25 LPs$56.8MAUM

ARTIS TECHBIO SELECT I, L.P.Mar 2026 · 30 LPs$40.9MAUM

ARTIS TECHBIO I (OFFSHORE), L.P.Mar 2026 · 23 LPs$29.3MAUM

also operates 10 SPVs

Source: SEC Form ADV Schedule D and EDGAR Form D filings. AUM is gross asset value as reported by the adviser.

Latest on 𝕏

Artis Ventures @artisventures

🏠 At home, Affect Therapeutics delivered virtual care to thousands of patients struggling with substance abuse disorders, reporting retention and engagement outcomes twice those of traditional treatment programs

Feb 5, 2024

Artis Ventures @artisventures

🩻 In the clinic, Rad AI saved radiologists time with their #generativeai tools

Feb 5, 2024 · ♥ 1

Artis Ventures @artisventures

🧠 In clinical trials, Delix Therapeutics successfully launched the first-ever novel neuroplastogen trial, showing their lead asset is well-tolerated and has no psychedelic effects

Feb 5, 2024